Signpath Pharma Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include CureVac.
Founding Date | Founding Date 1990 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US |
Employees | Employees 61821% increase | Employees 82517% decrease |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) 648.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) €535.2m (FY, 2024) |
Net income | Net income ($164.1m) (FY, 2025) | Net income €162.2m (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 45m | Total funding raised $ 1.1b |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company